SA patient activists wants court to consider medicines access issue in Sanofi patent case
This article was originally published in Scrip
Executive Summary
A South African patent dispute concerning Sanofi's anticancer Taxotere (docetaxel) and Cipla's cut-price generic version of the product is expected to attract global attention, with the local HIV-focused advocacy group Treatment Action Campaign (TAC) urging the court to consider the right of access to healthcare services when it decides on the case.